AAAAAA
Results:
1-10
|
Results: 10
Authors:
DAMBRA MN
GRAY RJ
HILLMAN R
JONES JW
KIM HC
RAWITSCHER R
SCHNAPER H
SZYMANSKI I
VLAHAKES GJ
KAPLAN D
LYNCH KE
GUILFOYLE M
ABELS RI
Citation: Mn. Dambra et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON TRANSFUSION RISK IN CORONARY-BYPASS PATIENTS, The Annals of thoracic surgery, 64(6), 1997, pp. 1686-1693
Authors:
PRICE TH
GOODNOUGH LT
VOGLER WR
SACHER RA
HELLMAN RM
JOHNSTON MFM
BOLGIANO DC
ABELS RI
Citation: Th. Price et al., THE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON THE EFFICACY OF AUTOLOGOUS BLOOD DONATION IN PATIENTS WITH LOW HEMATOCRITS - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL, Transfusion, 36(1), 1996, pp. 29-36
Authors:
FARIS PM
RITTER MA
ABELS RI
BALL GV
BERNINI PM
BRYANT GL
CAPERTON EM
CHRISTOFERSON LA
DEANDRADE JR
ENGH G
FURMAN W
HARMON JV
HILLMAN RS
HONIG S
INCAVO S
JOVE M
LANDON GC
NICHOLLS P
SAVORY CG
SCULCO T
SLAGIS SV
WOODSON R
Citation: Pm. Faris et al., THE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PERIOPERATIVE TRANSFUSION REQUIREMENTS IN PATIENTS HAVING A MAJOR ORTHOPEDIC OPERATION, Journal of bone and joint surgery. American volume, 78A(1), 1996, pp. 62-72
Authors:
SHANNON KM
KEITH JF
MENTZER WC
EHRENKRANZ RA
BROWN MS
WIDNESS JA
GLEASON CA
BIFANO EM
MILLARD DD
DAVIS CB
STEVENSON DK
ALVERSON DC
SIMMONS CF
BRIM M
ABELS RI
PHIBBS RH
Citation: Km. Shannon et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN STIMULATES ERYTHROPOIESIS AND REDUCES ERYTHROCYTE TRANSFUSIONS IN VERY-LOW-BIRTH-WEIGHT PRETERM INFANTS, Pediatrics, 95(1), 1995, pp. 1-8
Authors:
ROSE EH
ABELS RI
NELSON RA
MCCULLOUGH DM
LESSIN L
Citation: Eh. Rose et al., THE USE OF RHUEPO IN THE TREATMENT OF ANEMIA RELATED TO MYELODYSPLASIA (MDS), British Journal of Haematology, 89(4), 1995, pp. 831-837
Authors:
ROTH D
SMITH RD
SCHULMAN G
STEINMAN TI
HATCH FE
RUDNICK MR
SLOAND JA
FREEDMAN BI
WILLIAMS WW
SHADUR CA
BENZ RL
TEEHAN BP
REVICKI DA
SAROKHAN BJ
ABELS RI
Citation: D. Roth et al., EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS, American journal of kidney diseases, 24(5), 1994, pp. 777-784
Authors:
HENRY DH
ABELS RI
Citation: Dh. Henry et Ri. Abels, RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER AND CHEMOTHERAPY-INDUCED ANEMIA - RESULTS OF DOUBLE-BLIND AND OPEN-LABEL FOLLOW-UP-STUDIES, Seminars in oncology, 21(2), 1994, pp. 21-28
Authors:
GOODNOUGH LT
PRICE TH
FRIEDMAN KD
JOHNSTON M
CIAVARELLA D
KHAN N
SACHER R
VOGLER WR
WISSEL M
ABELS RI
Citation: Lt. Goodnough et al., A PHASE-III TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN NONANEMIC ORTHOPEDIC PATIENTS SUBJECTED TO AGGRESSIVE REMOVAL OF BLOOD FORAUTOLOGOUS USE - DOSE, RESPONSE, TOXICITY, AND EFFICACY, Transfusion, 34(1), 1994, pp. 66-71
Authors:
CASE DC
BUKOWSKI RM
CAREY RW
FISHKIN EH
HENRY DH
JACOBSON RJ
JONES SE
KELLER AM
KUGLER JW
NICHOLS CR
SALMON SE
SILVER RT
STORNIOLO AM
WAMPLER GL
DOOLEY CM
LARHOLT KM
NELSON RA
ABELS RI
Citation: Dc. Case et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY, Journal of the National Cancer Institute, 85(10), 1993, pp. 801-806
Authors:
ABELS RI
HENRY DH
Citation: Ri. Abels et Dh. Henry, PREDICTING RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESPONSE, Annals of internal medicine, 119(1), 1993, pp. 91-92
Risultati:
1-10
|